227 related articles for article (PubMed ID: 33353943)
1. The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences.
Pan JW; Zabidi MMA; Ng PS; Meng MY; Hasan SN; Sandey B; Sammut SJ; Yip CH; Rajadurai P; Rueda OM; Caldas C; Chin SF; Teo SH
Nat Commun; 2020 Dec; 11(1):6433. PubMed ID: 33353943
[TBL] [Abstract][Full Text] [Related]
2. TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects.
Ragu ME; Lim JMC; Ng PS; Yip CH; Rajadurai P; Teo SH; Pan JW
Breast Cancer Res; 2023 Apr; 25(1):48. PubMed ID: 37101199
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.
Kan Z; Ding Y; Kim J; Jung HH; Chung W; Lal S; Cho S; Fernandez-Banet J; Lee SK; Kim SW; Lee JE; Choi YL; Deng S; Kim JY; Ahn JS; Sha Y; Mu XJ; Nam JY; Im YH; Lee S; Park WY; Nam SJ; Park YH
Nat Commun; 2018 Apr; 9(1):1725. PubMed ID: 29713003
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
5. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations.
Yu K; Lee CH; Tan PH; Tan P
Clin Cancer Res; 2004 Aug; 10(16):5508-17. PubMed ID: 15328190
[TBL] [Abstract][Full Text] [Related]
6. HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA; López-Knowles E; Morani G; Tovey H; Kilburn L; Schuster EF; Alataki A; Hills M; Xiao H; Holcombe C; Skene A; Robertson JF; Smith IE; Bliss JM; Dowsett M; Cheang MCU;
EBioMedicine; 2022 Sep; 83():104205. PubMed ID: 35985932
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
8. p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.
Yamamoto M; Hosoda M; Nakano K; Jia S; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Cancer Sci; 2014 Jan; 105(1):81-8. PubMed ID: 24118529
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer.
Ju J; Du F; Gao SL; Si YR; Hu NL; Liu DX; Wang X; Yue J; Zheng FC; Kang YK; Yang ZX; Ma F; Xu BH; Yuan P
Breast Cancer Res Treat; 2022 Jul; 194(2):221-230. PubMed ID: 35699854
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network
Nature; 2012 Oct; 490(7418):61-70. PubMed ID: 23000897
[TBL] [Abstract][Full Text] [Related]
11. Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.
Tuna M; Smid M; Zhu D; Martens JW; Amos CI
PLoS One; 2010 Nov; 5(11):e15094. PubMed ID: 21152100
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients.
Deng L; Zhu X; Sun Y; Wang J; Zhong X; Li J; Hu M; Zheng H
Cancer Res Treat; 2019 Jan; 51(1):128-140. PubMed ID: 29540052
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women.
Selvarajan S; Wong KY; Khoo KS; Bay BH; Tan PH
Pathology; 2006 Dec; 38(6):528-33. PubMed ID: 17393979
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Pitt JJ; Riester M; Zheng Y; Yoshimatsu TF; Sanni A; Oluwasola O; Veloso A; Labrot E; Wang S; Odetunde A; Ademola A; Okedere B; Mahan S; Leary R; Macomber M; Ajani M; Johnson RS; Fitzgerald D; Grundstad AJ; Tuteja JH; Khramtsova G; Zhang J; Sveen E; Hwang B; Clayton W; Nkwodimmah C; Famooto B; Obasi E; Aderoju V; Oludara M; Omodele F; Akinyele O; Adeoye A; Ogundiran T; Babalola C; MacIsaac K; Popoola A; Morrissey MP; Chen LS; Wang J; Olopade CO; Falusi AG; Winckler W; Haase K; Van Loo P; Obafunwa J; Papoutsakis D; Ojengbede O; Weber B; Ibrahim N; White KP; Huo D; Olopade OI; Barretina J
Nat Commun; 2018 Oct; 9(1):4181. PubMed ID: 30327465
[TBL] [Abstract][Full Text] [Related]
16. Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer.
Zhao S; Liu XY; Jin X; Ma D; Xiao Y; Shao ZM; Jiang YZ
Theranostics; 2019; 9(17):4935-4945. PubMed ID: 31410192
[No Abstract] [Full Text] [Related]
17. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Bertucci F; Rypens C; Finetti P; Guille A; Adélaïde J; Monneur A; Carbuccia N; Garnier S; Dirix P; Gonçalves A; Vermeulen P; Debeb BG; Wang X; Dirix L; Ueno NT; Viens P; Cristofanilli M; Chaffanet M; Birnbaum D; Van Laere S
Mol Oncol; 2020 Mar; 14(3):504-519. PubMed ID: 31854063
[TBL] [Abstract][Full Text] [Related]
18. Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.
Li K; Liao N; Chen B; Zhang G; Wang Y; Guo L; Wei G; Jia M; Wen L; Ren C; Cao L; Mok H; Li C; Lin J; Chen X; Zhang Z; Hou T; Li M; Liu J; Balch CM; Liao N
Breast Cancer Res Treat; 2020 Sep; 183(2):321-332. PubMed ID: 32638235
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women.
Lee JS; Lo PK; Fackler MJ; Argani P; Zhang Z; Garrett-Meyer E; Sukumar S
Cancer Biol Ther; 2007 Jul; 6(7):1114-20. PubMed ID: 17611401
[TBL] [Abstract][Full Text] [Related]
20. Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.
Dobes P; Podhorec J; Coufal O; Jureckova A; Petrakova K; Vojtesek B; Hrstka R
Oncol Rep; 2014 Oct; 32(4):1695-702. PubMed ID: 25051299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
